Resources Blog 4th Fc-Mediated Function Summit 2024 – Boston: Event Recap

4th Fc-Mediated Function Summit 2024 – Boston: Event Recap

Biointron 2024-04-22 Read time: 3 mins

4th-Fc-mediated-Function-Summit.png

The 4th Fc-Mediated Function Summit 2024 was held in Boston, MA from April 17-18, and focused on discussions supercharging FcRn, FcγR, and IgG to advance molecular development, clinical utility, and novel therapeutic applications. During the event, industry experts from across the globe gathered to share the latest research in Fc biology insights, including:

  • Translating Fc Biology Insights to Innovate Drug Design

  • Fc Receptor Role in IO Drug Development to Transfer in Autoimmunity

  • Developing Antibody Target Engagement & Fc-Mediated Function

  • Targeting FcγR - What is the Next Mutation?


Biointron Summary Report:

1. Innovative Drug Design

  • Understanding Fc biology, effector functions, and inhibitors to discover opportunities to improve antibody therapeutics.

  • Using Fc Factor 8 to activate NK cells for specific targeting of unwanted B-cells.

  • Showcase of mouse models expressing human Fc receptors as tools for translational assessment of Fc receptor-targeted therapies.

2. Autoimmunity

  • Systemic IgA may be exploited for potential novel therapeutics strategies against infectious disease.

  • Next generation formats like tetravalent bispecific antibodies in the Fc are beneficial for cancer immunotherapy.

  • The combination of checkpoint blocking and Fc-mediated tumor cell killing can lead to novel cancer therapeutics.

3. Fc-Mediated Functions

  • Engineered antibody and albumin molecules with tailored binding and transport properties was discussed.

  • Evaluation of the main Fc silencing mutations, and what specific needs there are is useful for enhancing diesign optimization.

4. Targeting FcγR

  • Using the potential of Fc gamma receptors to tune antibody-based immunotherapy with tailored FcgR-blockade.

  • PD-1 agonist antibodies rely on the mediated clustering of FcγRs to trigger their sppresive function.


Thank you to everyone who visited our booth at the 4th Fc-Mediated Function Summit 2024 to learn about our services! We had a fantastic time chatting with you and how it can help you achieve antibody development. Our expert team would be happy to answer any follow-up questions. Feel free to email us at info@biointron.com or visit our website at www.biointron.com.

Subscribe to our Blog

Recent Blog

In vivo research plays a pivotal role in the development of innovative therapeutics, particularly biologics. As researchers and drug developers continue to explore new targets and refine existing therapies, high-quality research tools like Benchmark Positive Antibodies are essential. These anti-huma

Sep 11, 2024
Blog

Antibodies have applications across research, diagnostics, and therapeutics. Their high specificity, selectivity, and ability to recognize and bind to specific antigens makes them essential for applications like selection, identification, purification, and disease treatment. Antibodies are generally categorized into two main groups: polyclonal antibodies (pAbs) and monoclonal antibodies (mAbs).

Sep 10, 2024
Blog

The 15th Annual World Bispecifics Summit 2024 was held in Boston, MA on September 3-5, 2024. The event brought together experts in the field of bi, tri and multi-specifics, in addition to bispecific ADCs and BiTEs.

Sep 09, 2024
Blog

The neonatal Fc receptor, or FcRn, plays an important role in both maternal IgG transport and protection of IgG from degradation.

Sep 09, 2024
Blog

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.